Human pancreatic islet 3D chromatin architecture provides insights into the genetics of type 2 diabetes
Irene Miguel-EscaladaiD, Sílvia Bonàs‐GuarchiD, Inês CebolaiD, Joan Ponsa-CobasiD, Julen Mendieta-EstebaniD, Goutham AtlaiD, Biola M. JavierreiD, Delphine Rolando, Irene FarabellaiD, Claire C. MorganiD, Javier García-HurtadoiD, Anthony BeucheriD, Ignasi MorániD, Lorenzo PasqualiiD, Mireia Ramos-RodrígueziD, Emil V. R. AppeliD, Allan R LinnebergiD, Anette P. GjesingiD, Daniel R. WitteiD, Oluf Borbye PederseniD, Niels GrarupiD, Philippe RavassardiD, David TorrentsiD, Josep Maria MercaderiD, Lorenzo PiemontiiD, , Jorge P. FerreriD
Abstract
Genetic studies promise to provide insight into the molecular mechanisms underlying type 2 diabetes (T2D). Variants associated with T2D are often located in tissue-specific enhancer regions (enhancer clusters, stretch enhancers or super-enhancers). So far, such domains have been defined through clustering of enhancers in linear genome maps rather than in 3D-space. Furthermore, their target genes are generally unknown. We have now created promoter capture Hi-C maps in human pancreatic islets. This linked diabetes-associated enhancers with their target genes, often located hundreds of kilobases away. It further revealed sets of islet enhancers, super-enhancers and active promoters that form 3D higher-order hubs, some of which show coordinated glucose-dependent activity. Hub genetic variants impact the heritability of insulin secretion, and help identify individuals in whom genetic variation of islet function is important for T2D. Human islet 3D chromatin architecture thus provides a framework for interpretation of T2D GWAS signals.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 282
- FWCI
- 12.33
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci
Matthias Thurner, Martijn van de Bunt, … Mark I. McCarthy·eLifePeer-reviewed·Feb 7, 2018
- Pancreatic islet chromatin accessibility and conformation defines distal enhancer networks of type 2 diabetes risk
William W. Young Greenwald, Joshua Chiou, … Kyle J. Gaulton·Nature CommunicationsPeer-reviewed·May 7, 2019
- Islet-specific DNA hypomethylation identifies gene enhancer loci driving Type 2 Diabetes risk
Verda E. Miranda, Timothy J. Scott, … Emily C. Hodges·medRxiv·Sep 9, 2025
- The three-dimensional chromatin structure of the major human pancreatic cell types reveals lineage-specific regulatory architecture of T2D risk
Chun Su, Long Gao, … Klaus H. Kaestner·bioRxiv·Nov 30, 2021
- Chromatin 3D interaction analysis of the STARD10 locus unveils FCHSD2 as a new regulator of insulin secretion
M. Hu, I. Cebola, … G. A. Rutter·bioRxiv·Mar 31, 2020
- Influence of genetic variants on gene expression in human pancreatic islets - implications for type 2 diabetes
Ana Viñuela, Arushi Varshney, … Mark I. McCarthy·Nature CommunicationsPeer-reviewed·Sep 30, 2020